3:59pm PDT - April 21st, 2023

Universal Influenza Candidate Vaccine Performs Well in Phase 1 Trial | NIH: National Institute of Allergy and Infectious Diseases https://t.co/l8JRP3If2U

0 retweets   0 likes  - OSAP.org (@OSAPtweets)